4
Changes in Ownership
LIGAND PHARMACEUTICALS INC Filed Acc 0001104659-24-031806
Director sold 1,893 shares at $74.30 ($140,650)
- Director acquired 2,893 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Sabba Stephen L · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-03-05 | Exercise or conversion : show line 1 in the form | +2,893 | 30,819 | D | ||
| 2024-03-05 | Sale : show line 2 in the form | −1,893 | $74.30 | $140,650 | 28,926 | D |
| Open-market sales · 1,893 sh · avg $74.30 · $140,650 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-03-05 | Exercise or conversion : show line 3 in the form Non-Qualified Stock Option (right to buy) | −2,893 | 419 | D |
Loading xslF345X05/tm248239-1_4seq1.xml…